The product candidate has received multiple IND approvals from both the US FDA and Chinese NMPA... Jan 18
... Jan 18
GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ... Jan 18
In the US, gastric cancer is most frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving beyond five years.... Jan 18
Each additional daily cup associated with reduction in risk of nearly 1% ... Jan 18
... Jan 16
GT Molecular, a leader in wastewater-based epidemiological testing, has reported the detection of hyper-transmissible SARS-CoV-2 from the B.1.1.7 ... Jan 16
New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ... Jan 15
XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people ... Jan 15
... Jan 13
Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the ... Jan 13
The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ... Jan 13
Benefits of health apps for patients elaborated by Mr Prem Sharma CEO, DaytoDay Health... Jan 12
The pharma stocks for long term wealth creation ... Jan 11
Unsafe food containing harmful bacteria, viruses, parasites, or chemical substances, causes more than 200 diseases – ranging from diarrhea to cancers.... Jan 08
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
Top ten pharma stocks January 2021... Jan 06
... Jan 05
IIT Delhi collaborates with AIIA to work on seven collaborative projects focusing on various Ayurvedic formulations and practices... Jan 04
Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001 ... Jan 01
The drugs discovery program is for servicing the US$111.2B global Metastatic Cancer market... Dec 31
The FDA grants orphan drug designation to drugs and biologics that are intended for the treatment of rare diseases that affect fewer than 200,000 ... Dec 30
Committee of experts to soon give report on the process of identifying and prioritizing patients with co-morbidities, for the purpose of vaccination: Member (Health), ... Dec 30
Annamycin is capable of reaching 6 to 34-fold higher levels of accumulation in the lungs than that of doxorubicin, the primary first-line chemotherapy ... Dec 29
LORBRENA is a third-generation ALK inhibitor specifically developed to inhibit the most common tumour mutations that drive resistance to current medications and to address ... Dec 29
Tuesday, January 19, 2021
